Description: In this study day I describe and explain the unique cellular and genetic features of cancers affecting white blood cells. And I go through the scientific logic behind a diverse range of targeted treatments licensed for these cancers such as anti-CD20 monoclonal antibodies, B cell receptor signalling blockers and JAK2 inhibitors. I also include upcoming treatments such as Bcl-2, FLT3 and CDK inhibitors, anti-PD-1 antibodies, and new antibodies for multiple myeloma.
Audience: Ideal for research nurses, pharmacists, pharmaceutical companies, junior doctors or anyone who has been on one of my other courses
Book your place online, or call the Marsden’s education centre to book your place on 020 7808 2921.